Position in VERA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$20,897,270
-$3,066,537 QoQ
Shares Held
519,445
+9.8% QoQ
Ownership
0.724%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 98.32051516522442.ToString("F0")%
Shared 1.6794848347755778.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VERA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $6,613,450,444 across 417 Biotechnology names. VERA ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,564,264 | $1,145,046,441 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
941,941 | $727,781,290 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
858,120 | $283,926,160 | |
| 4 | INSM |
INSMED Inc
|
1,294,000 | $211,594,876 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,808,735 | $182,705,014 | |
| 6 | INCY |
Incyte Corp
|
1,849,726 | $174,096,208 | |
| 7 | MRNA |
Moderna, Inc.
|
2,952,041 | $149,963,680 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,403,642 | $104,234,453 |
All Filings in VERA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,897,270 | 519,445 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $23,963,807 | 473,219 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $13,404,211 | 461,260 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $10,849,613 | 460,510 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $10,046,578 | 418,259 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,242,244 | 455,007 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $16,146,260 | 365,300 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $13,224,476 | 365,519 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,060,216 | 372,454 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,949,820 | 321,835 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,051,358 | 295,504 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,453,280 | 277,463 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,500,667 | 193,385 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,428,056 | 125,481 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,447,879 | 114,870 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,530,716 | 112,470 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,569,969 | 109,407 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,080,231 | 77,853 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,029,114 | 59,315 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||